IndiaInfoline » Markets »
Shukra Pharmaceuticals Ltd - Share Price
Shukra Pharmaceuticals LtdFinancials
Shukra Pharmaceuticals LtdNews & Updates
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | 1,034.65 | 94.54 | 247,923.28 | 1,213.01 | 0.97 | 5,181.72 | 108.48 |
| Cipla Ltd | 1,096.50 | 31.64 | 89,191.08 | 720.30 | 0.45 | 3,746.06 | 291.80 |
| Divis Laboratories Ltd | 3,382.90 | 29.88 | 88,708.98 | 486.85 | 0.90 | 1,823.38 | 454.85 |
| Dr Reddys Laboratories Ltd | 4,396.00 | 30.95 | 73,559.84 | 1,116.30 | 0.68 | 4,866.10 | 1,156.40 |
| Torrent Pharmaceuticals Ltd | 1,623.50 | 55.67 | 55,107.38 | 272.00 | 1.47 | 1,906.00 | 191.38 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Shukra Pharmaceuticals LtdSummary & Reports
Relish Pharmaceuticals Ltd is a public limited company with a global perspective, manufacturing, exporting and marketing in both domestic and international markets. The company was incorporated on March 4, 1993 as a private limited company with the name Relish Pharmaceuticals Pvt Ltd. In August 31, 1993, the company was converted into a public limited company and the name was changed to Relish Pharmaceuticals Ltd.The company provides v... More
Registered Office
3 rd Floor Dev House,Opp WIAA Office Judges Bungalo,Ahmedabad, Gujarat,380054
Tell. : +91-079-66522247/27498515
Website : http://www.relishpharma.com
Email : info@relishpharma.com
Registrar Office
9 ShivShakti Indl Es, Lower Parel, Mumbai - 400 011 INDIA
Tell. : +91-22-23016761/8261
Website :
Email :
Reports by shukra-pharmaceuticals-ltd-share-price
Latest Release by shukra-pharmaceuticals-ltd-share-price
IIFLView
-
Reco. Price
0.00
Nov 28, 2022
Target Price
0.00
Target Returns:
0.00%
Shareholding Snapshot
Loading ...
| Sep - 2022 | |
|---|---|
| Promoter | - |
| Foreign | 0.00% |
| Indian | 49.17% |
| Total Promoter | 49.17% |
| Non Promoter | - |
| Institutions | 0.80% |
| Non-Institutions | 50.04% |
| Total Non-Promoter | 50.83% |
| Custodian | 0.00% |
| Total | 100% |
Corporate Action
Purpose
Board Meeting
Exp. Date
12 Nov 2022
Annc. Date
03 Nov 2022
Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company... More
Purpose
AGM
Exp. Date
29 Sep 2022
Annc. Date
12 Sep 2022
AGM 29/09/20221) Approval and adoption of Directors Report and Secretarial Audit Report for the year... More
Purpose
Dividend
Annc. Date
28 May 2022
Effective. Date
22 Sep 2022
Divi. Type
Final
Divi.(%)
5
Divi. Amt.
0.5
The Board of Directors of the Company in their meeting held to-day have approved and taken on record... More
